Meristem Family Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.34M Buy
28,566
+1,310
+5% +$103K 0.25% 44
2021
Q4
$2.09M Sell
27,256
-676
-2% -$53.8K 0.18% 62
2021
Q3
$2.1M Buy
27,932
+8,940
+47% +$680K 0.2% 59
2021
Q2
$1.48M Sell
18,992
-2,105
-10% -$157K 0.23% 53
2021
Q1
$1.55M Sell
21,097
-7,027
-25% -$518K 0.31% 40
2020
Q4
$2.19M Buy
28,124
+7,084
+34% +$542K 0.47% 32
2020
Q3
$1.67M Sell
21,040
-500
-2% -$39.2K 0.43% 36
2020
Q2
$1.59M Buy
21,540
+174
+0.8% +$13.1K 0.44% 35
2020
Q1
$1.57M Sell
21,366
-125
-0.6% -$9.82K 0.48% 35
2019
Q4
$1.86M Hold
21,491
0.46% 36
2019
Q3
$1.73M Sell
21,491
-2,642
-11% -$212K 0.47% 36
2019
Q2
$1.93M Buy
24,133
+2,458
+11% +$188K 0.59% 31
2019
Q1
$1.72M Sell
21,675
-112
-0.5% -$8.38K 0.58% 30
2018
Q4
$1.59M Buy
21,787
+94
+0.4% +$6.64K 0.58% 30
2018
Q3
$1.47M Hold
21,693
0.5% 29
2018
Q2
$1.26M Sell
21,693
-1,886
-8% -$106K 0.44% 31
2018
Q1
$1.23M Buy
23,579
+961
+4% +$51.9K 0.44% 34
2017
Q4
$1.21M Buy
22,618
+87
+0.4% +$4.82K 0.44% 35
2017
Q3
$1.38M Hold
22,531
0.55% 27
2017
Q2
$1.38M Hold
22,531
0.57% 28
2017
Q1
$1.37M Sell
22,531
-419
-2% -$25.4K 0.54% 27
2016
Q4
$1.29M Sell
22,950
-1,467
-6% -$85.9K 0.53% 31
2016
Q3
$1.45M Buy
24,417
+1,026
+4% +$60K 0.61% 29
2016
Q2
$1.29M Sell
23,391
-194
-0.8% -$10.3K 0.57% 28
2016
Q1
$1.19M Hold
23,585
0.53% 27
2015
Q4
$1.19M Buy
23,585
+226
+1% +$11.4K 0.47% 31
2015
Q3
$1.1M Buy
23,359
+298
+1% +$15.8K 0.58% 28
2015
Q2
$1.25M Hold
23,061
0.55% 28
2015
Q1
$1.26M Hold
23,061
0.53% 29
2014
Q4
$1.25M Sell
23,061
-87
-0.4% -$4.85K 0.46% 33
2014
Q3
$1.31M Sell
23,148
-1,405
-6% -$78.9K 0.56% 31
2014
Q2
$1.35M Sell
24,553
-53
-0.2% -$2.89K 0.57% 30
2014
Q1
$1.33M Sell
24,606
-1,362
-5% -$70.5K 0.58% 30
2013
Q4
$1.24M Sell
25,968
-1,439
-5% -$65.8K 0.51% 34
2013
Q3
$1.25M Sell
27,407
-2
-0% -$91 0.57% 32
2013
Q2
$1.22M Buy
+27,409
New +$1.22M 0.56% 31

Other funds holding MRK

Meristem Family Wealth's MRK Position: Q1 2022 in Review

Meristem Family Wealth increased its Merck (MRK) stake by 4.8% in Q1 2022, buying an estimated $103K and bringing the position to 28,566 shares worth $2.34M. The position accounts for 0.25% of the portfolio, ranked #44.

Meristem Family Wealth first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Meristem Family Wealth held 28,566 shares of Merck worth $2.34M as of Q1 2022.
  • Meristem Family Wealth bought 1,310 Merck shares in Q1 2022, an estimated $103K.
  • Merck made up 0.25% of Meristem Family Wealth's portfolio in Q1 2022, its #44 holding.
  • Meristem Family Wealth first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
  • 2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.